These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 36818932)

  • 21. Self-assessment of oral health, dental health care and oral health-related quality of life among Parkinson's disease patients.
    Barbe AG; Bock N; Derman SH; Felsch M; Timmermann L; Noack MJ
    Gerodontology; 2017 Mar; 34(1):135-143. PubMed ID: 27231151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sialorrhea: a management challenge.
    Hockstein NG; Samadi DS; Gendron K; Handler SD
    Am Fam Physician; 2004 Jun; 69(11):2628-34. PubMed ID: 15202698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A study of salivary secretion in Parkinson's disease.
    Bagheri H; Damase-Michel C; Lapeyre-Mestre M; Cismondo S; O'Connell D; Senard JM; Rascol O; Montastruc JL
    Clin Neuropharmacol; 1999; 22(4):213-5. PubMed ID: 10442250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and efficacy of botulinum toxin type B for treatment of sialorrhea in Parkinson's disease: a prospective double-blind trial.
    Chinnapongse R; Gullo K; Nemeth P; Zhang Y; Griggs L
    Mov Disord; 2012 Feb; 27(2):219-26. PubMed ID: 21887710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Facts and controversies regarding oral health in Parkinson's disease: A case-control study in Spanish patients.
    García-De-La-Fuente AM; Lafuente-Ibáñez-de-Mendoza I; Lartitegui-Sebastián MJ; Marichalar-Mendia X; Echebarria-Goikouria MÁ; Aguirre-Urizar JM
    Med Oral Patol Oral Cir Bucal; 2022 Sep; 27(5):e419-e425. PubMed ID: 35368008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sialorrhoea and drooling in patients with Parkinson's disease: epidemiology and management.
    Merello M
    Drugs Aging; 2008; 25(12):1007-19. PubMed ID: 19021300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyposalivation and xerostomia among Parkinson's disease patients and its impact on quality of life.
    Barbe AG; Heinzler A; Derman S; Hellmich M; Timmermann L; Noack MJ
    Oral Dis; 2017 May; 23(4):464-470. PubMed ID: 27976483
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Digestive disorders in Parkinson's disease: dysphagia and sialorrhea].
    González-Fernández J; Prieto-Albin R; Velasco-Palacios L; Jorge-Roldán S; Cubo-Delgado E
    Rev Neurol; 2010 Feb; 50 Suppl 2():S51-4. PubMed ID: 20205142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Salivary Secretory Disorders, Inducing Drugs, and Clinical Management.
    Miranda-Rius J; Brunet-Llobet L; Lahor-Soler E; Farré M
    Int J Med Sci; 2015; 12(10):811-24. PubMed ID: 26516310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Botulinum toxin for treatment of parkinsonian sialorrhea.
    Friedman A; Potulska A
    Neurol Neurochir Pol; 2001; 35 Suppl 3():23-7. PubMed ID: 12001650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gut dysfunction in Parkinson's disease.
    Mukherjee A; Biswas A; Das SK
    World J Gastroenterol; 2016 Jul; 22(25):5742-52. PubMed ID: 27433087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological interventions for preventing dry mouth and salivary gland dysfunction following radiotherapy.
    Riley P; Glenny AM; Hua F; Worthington HV
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD012744. PubMed ID: 28759701
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Xerostomia and dysphagia].
    Takahashi K
    Clin Calcium; 2012 Jan; 22(1):59-65. PubMed ID: 22201100
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Diagnostic value of saliva].
    Michels LF
    Ned Tijdschr Tandheelkd; 1992 Mar; 99(3):89-91. PubMed ID: 11819986
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does Botulinum neurotoxin type A treatment for sialorrhea change oral health?
    Tiigimäe-Saar J; Taba P; Tamme T
    Clin Oral Investig; 2017 Apr; 21(3):795-800. PubMed ID: 27114092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recommendations for a paradigm shift in approach to increase the recognition and treatment of sialorrhea in Parkinson's disease.
    Bergmans B; Clark V; Isaacson SH; Bäumer T
    Clin Park Relat Disord; 2023; 9():100223. PubMed ID: 38021341
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ipratropium bromide spray as treatment for sialorrhea in Parkinson's disease.
    Thomsen TR; Galpern WR; Asante A; Arenovich T; Fox SH
    Mov Disord; 2007 Nov; 22(15):2268-73. PubMed ID: 17876852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Botulinum toxin A as treatment for drooling saliva in PD.
    O'Sullivan JD; Bhatia KP; Lees AJ
    Neurology; 2000 Aug; 55(4):606-7. PubMed ID: 10953215
    [No Abstract]   [Full Text] [Related]  

  • 39. The option of sonographic guidance in Botulinum toxin injection for drooling in Parkinson's disease.
    Jost WH
    J Neural Transm (Vienna); 2016 Jan; 123(1):51-5. PubMed ID: 26138438
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dysphagia and sialorrhea: the relationship to Parkinson's disease.
    Nicaretta DH; Rosso AL; Mattos JP; Maliska C; Costa MM
    Arq Gastroenterol; 2013; 50(1):42-9. PubMed ID: 23657306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.